Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home » Research

Research

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 15/11/23 by Chengsheng Ju

Impact of an Incident Cancer Diagnosis on the Use of Guideline-Directed Medical Therapy for Heart Failure: a Longitudinal Study

Abstracts

View resources
Last reviewed: 15/11/23 by David Kaye

Multiple Dosing with Infliximab for Immune Colitis Due to Checkpoint Inhibitor Therapy Does Not Adversely Affect Outcomes

Abstracts

View resources
Last reviewed: 15/11/23 by David Kaye

Cytomegalovirus (CMV) Infection in Patients Treated with Infliximab for Immune Related Colitis Due to Checkpoint Inhibitors

Abstracts

View resources
Last reviewed: 15/11/23 by David Kaye

Immunoglobulin Use in Patients Undergoing Treatment with Checkpoint Inhibitors

Abstracts

View resources
Last reviewed: 15/11/23 by Amal Khlafa

Increasing Awareness and Engagement with Bowel Cancer Screening Amongst Ethnic Minorities: a Controlled Interventional Study in Community Pharmacies

Abstracts

View resources
Last reviewed: 15/11/23 by Priya Khoda

A Retrospective Review of the Use of Trastuzumab and Pertuzumab in the Treatment of HER2+ve Salivary Gland Tumour

Abstracts

View resources
Last reviewed: 15/11/23 by Sarthika Maggo

The Experience of People from Ethnic Minorities with Their Cancer Journey: How Can Healthcare Professionals Create an Inclusive Environment?

Abstracts

View resources
Last reviewed: 15/11/23 by Faiqa Javaid

Evaluating the Safety of Sacituzumab Govitecan without H2-Antagonist Premedication

Abstracts

View resources
Last reviewed: 15/11/23 by Alexandra Van Slageren

Evaluating the Safety of Administering Bortezomib or Carfilzomib using Haematological Parameters from Day 1

Abstracts

View resources
Last reviewed: 15/11/23 by Inisa Idress

Evaluation of Left Ventricular Ejection Fraction Monitoring during HER-2 Targeted Therapy

Abstracts

View resources
Last reviewed: 15/11/23 by Jurga McLean

Focus Group Exploring Patient’s Perceptions of Cancer Treatments and Blood Sampling

Abstracts

View resources
Last reviewed: 15/11/23 by Hasan Kobat

Investigating QTc Prolongation Induced by Tyrosine-Kinase Inhibitors: A Global Survey

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 2 3 … 10 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.